FindTrial
Sign In

Ultrasound-guided radiofrequency ablation versus cinacalcet in the treatment of secondary hyperparathyroidism: a retrospective study

Ultrasound-guided radiofrequency ablation versus cinacalcet in the treatment of secondary hyperparathyroidism: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095219
Enrollment
Unknown
Registered
2025-01-03
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary hyperparathyroidism

Interventions

radiofrequency ablation group:None
cinacalcet group:None

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Hyperparathyroidism confirmed by ultrasound and TcMIBI; 2. Contraindication or refuse to surgery.

Exclusion criteria

Exclusion criteria: 1. History of osteolytic malignancy within the past 5 years; 2. Being treated with thiazide diuretics or lithium; 3.Lack of baseline information or refusal to participate in follow-up.

Design outcomes

Primary

MeasureTime frame
parathyroid hormone;—

Secondary

MeasureTime frame
calcium;phosphorus;alkaline phosphatase;—

Countries

China

Contacts

Public ContactPeng Chengzhong

Shanghai Tenth People’s Hospital

pcz001@126.com+86 159 0190 8030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026